Synthesis and antibacterial activity of novel 6-O-substituted erythomycin A derivatives

Bioorganic and Medicinal Chemistry Letters

Volumn 10, Issue 8, 2000, Pages 815-819

  Clark, Richard F ^a   Ma, Zhenkun ^a   Wang, Sanyi ^a   Griesgraber, George ^a   Tufano, Michael ^a   Yong, Hong ^a   Li, Leping ^a   Zhang, Xiaolin ^a   Nilius, Angela M ^a   Chu, Daniel T W ^a   Or, Yat Sun ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; ERYTHROMYCIN DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; HAEMOPHILUS INFLUENZAE; IC 50; IN VITRO STUDY; NONHUMAN; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

ANTI-INFECTIVE AGENTS; ERYTHROMYCIN; MICROBIAL SENSITIVITY TESTS; STRUCTURE-ACTIVITY RELATIONSHIP;

BACTERIA (MICROORGANISMS); HAEMOPHILUS INFLUENZAE; NEGIBACTERIA; POSIBACTERIA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 0034678648     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(00)00106-2     Document Type: Article

References (23)

1. (a) Chu, D. T. W. Exp. Opin. Invest. Drugs 1995, 4, 65.
2. (b) Lartey, P. A.; Perun, T. In Studies in Natural Products Chemistry; Rahman, A., Ed.; Elsevier Science: Amsterdam, 1993; Vol. 13, pp 155-185.
3. Kurath P., Jones P., Egan R., Perun T. Experienta. 27:1971;362.
4. Itoh Z., Nakaya M., Suzuki T., Hiral H., Wakabayashi K. Am. J. Physiol. 10:1984;G688.
5. (a) Morimoto, S.; Takahashi, Y.; Watanabe, Y.; Omura, S. J. Antibiot. 1984, 37, 187.
6. (b) Watanabe, Y.; Morimoto, S.; Adachi, T.; Kashimura, M.; Asaka, T. J. Antibiot. 1993, 46, 647.
7. Morimoto S., Takahashi Y., Adachi T., Nagate T., Watanabe Y., Omura S. J. Antibiot. 43:1990;286.
8. (a) Fernandes, P. B.; Baker, W. R.; Freiberg, L. A.; Hardy, D. J.; McDonald, E. D. Antimicrob. Agents Chemother. 1989, 33, 78.
9. (b) Agouridas, C.; Denis, A.; Auger, J.-M.; Benedetti, Y.; Bonnefoy, A.; Bretin, F.; Chantot, J.-F.; Dussarat, A.; Fromentin, C.; Gouin D'Ambrieres, S.; Lachaud, S.; Laurin, P.; Le Martret, O.; Loyau, V.; Tessot, N. J. Med. Chem. 1998, 41, 4080.
10. (c) Asaka, T.; Kashimura, M.; Misawa, Y.; Ono, T.; Suzuki, K.; Yoshida, T.; Akashi, T.; Yokoo, C.; Nagate, T.; Morimoto, S. Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 17-20 September 1995, Abstract No. F177.
11. (a) Neu, H. C. Science 1992, 257, 1064.
12. (b) Appelbaum, P. C. Clin. Infect. Dis., 1992, 15, 77.
13. (c) Katz, L.; Chu, D. T. W.; Plattner, J. J. J. Med. Chem. 1996, 39, 3853.
14. (d) Doern, G. V.; Jones, R. N.; Pfaller, M. A.; Kugler, K. Antimicrob. Agents Chemother. 1999, 43, 385.
15. Morimoto, S.; Adachi, T.; Matsunaga, T.; Kashimura, M.; Asaka, T.; Watanabe, Y.; Sota, K.; Sekiuchi, K. US Patent 4,990,602, 1991.
16. In general, sodium nitrite was found to be the preferred reagent giving higher yields of the deoximated products.
17. Heck, R. F. In Comprehensive Organic Synthesis; Trost, B. M., Ed.; Pergamon: New York, 1991; Vol. 4, Chapter 4.3.
18. Tsuji, J.; Shimizu, I.; Yamamoto, K. Tettrahedron Lett. 1976, 2975.
19. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; National Committee for Clinical Laboratory Standards: Villanova, PA, 1985: M7-A, Vol. 5, No. 22.
20. (a) Leclerc, R.; Courvalin, P. In Macrolides: Chemistry, Pharmacology and Clinical Uses; Bryskier, A. J.; Butzler, J.-P.; Neu, H. C.; Tulkens, P. M., Eds.; Arnette Blackwell: Paris, 1993; pp 125-141.
21. (b) Weisblum, B. Drug Resistance Updates 1998, 1, 29.
22. Sutcliffe J., Tait-Kamradt A., Wondrack L. Antimicrob. Agents Chemother. 40:1996;1817.
23. An early example of the successful application of this methodology has recently appeared: Ma, Z.; Clark, R. F.; Wang, S.; Nilius, A.; Flamm, R. K.; Or, Y. Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 26-29 September 1999, Abstract No. 2133.